Stéphane Méry
Vorstandsvorsitzender bei Contronics Ltd.
Profil
Stéphane R.
Méry currently works at Contronics Ltd., as Chief Executive Officer.
Dr. Méry also formerly worked at Smithkline Beecham Plc, as Associate Director-Worldwide Business Development, GSK Plc, as Associate Director-Worldwide Business Development, ImmuPharma Plc, as Independent Non-Executive Director from 2015 to 2021, Population Genetics Technologies Ltd., as Director, Domainex Ltd., as Non-Executive Director, PolyTherics Ltd., as Director, Altacor Ltd., as Non-Executive Director, Genex Biosystems Ltd., as Director, GlaxoSmithKline LLC, as Associate Director, Amati Global Investors Ltd.
(Venture Capital), as Director, Worldwide Business Development Corp., as Associate Director, Endomagnetics Ltd., as Director, Beringea LLP, as Partner from 2008 to 2014, and Bloomsbury Bioseed Fund Ltd, as Fund Manager from 2000 to 2020.
Dr. Méry received his Masters Business Admin degree from INSEAD.
Aktive Positionen von Stéphane Méry
| Unternehmen | Position | Beginn |
|---|---|---|
| Contronics Ltd. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Stéphane Méry
| Unternehmen | Position | Ende |
|---|---|---|
| IMMUPHARMA PLC | Direktor/Vorstandsmitglied | 30.07.2021 |
Bloomsbury Bioseed Fund Ltd
 Bloomsbury Bioseed Fund Ltd Investment ManagersFinance Bloomsbury Bioseed Fund Ltd. (Bloomsbury Bioseed Fund) is venture capital firm founded in 2000. The firm is headquartered in London, United Kingdom. | Private Equity Investor | 14.02.2020 |
Beringea LLP
 Beringea LLP Investment ManagersFinance Beringea LLP is an Independent Private Equity/Venture Capital firm founded in 1980 by Charlie Rothstein. Beringea LLP is headquartered in London. | Private Equity Investor | 01.12.2014 |
Genex Biosystems Ltd.
 Genex Biosystems Ltd. BiotechnologyHealth Technology Genex has developed the world's most efficient vector system (LipTide) for delivery of DNA, RNA and drugs into cells for gene expression, gene knockdown and drug therapy. LipTide technology is available for licensing to companies developing DNA or RNA based therapies. The company was founded in 2002 and is headquartered in London, GB. | Direktor/Vorstandsmitglied | 16.02.2012 |
Amati Global Investors Ltd. (Venture Capital)
 Amati Global Investors Ltd. (Venture Capital) Investment ManagersFinance Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh. | Private Equity Investor | 01.02.2009 |
Ausbildung von Stéphane Méry
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUPHARMA PLC | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 13 |
|---|---|
Population Genetics Technologies Ltd.
 Population Genetics Technologies Ltd. Miscellaneous Commercial ServicesCommercial Services Population Genetics Technologies Ltd. offers population genetics. The firm develops and patents technologies that find, characterize and quantify true genetic variants responsible for disease, disease resistance and drug response for agricultural biotechnology, infectious disease and cancer markets. The company was founded by Sydney Brenner, Sam Eletr, Philip Goelet and Nobel Laureate on April 30, 2004 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
Amati Global Investors Ltd. (Venture Capital)
Amati Global Investors Ltd. (Venture Capital) Investment ManagersFinance Amati Global Investors Ltd. (Venture Capital) is a Venture Capital firm, a subsidiary of Amati Global Investors Ltd. founded in 1999. The firm is headquartered in Edinburgh. | Finance |
Genex Biosystems Ltd.
Genex Biosystems Ltd. BiotechnologyHealth Technology Genex has developed the world's most efficient vector system (LipTide) for delivery of DNA, RNA and drugs into cells for gene expression, gene knockdown and drug therapy. LipTide technology is available for licensing to companies developing DNA or RNA based therapies. The company was founded in 2002 and is headquartered in London, GB. | Health Technology |
Beringea LLP
Beringea LLP Investment ManagersFinance Beringea LLP is an Independent Private Equity/Venture Capital firm founded in 1980 by Charlie Rothstein. Beringea LLP is headquartered in London. | Finance |
Altacor Ltd.
 Altacor Ltd. Pharmaceuticals: MajorHealth Technology Altacor Ltd. operates as a specialist ophthalmology company develops and markets a portfolio of products in the fields of dry eye, glaucoma and ocular infection. The company was founded by Francesca Elizabeth Crawford and David Francis Alcraft in 2007 and is headquartered in Theale, the United Kingdom. | Health Technology |
Bloomsbury Bioseed Fund Ltd
Bloomsbury Bioseed Fund Ltd Investment ManagersFinance Bloomsbury Bioseed Fund Ltd. (Bloomsbury Bioseed Fund) is venture capital firm founded in 2000. The firm is headquartered in London, United Kingdom. | Finance |
Endomagnetics Ltd.
 Endomagnetics Ltd. Packaged SoftwareTechnology Services Endomagnetics Ltd. develops surgical instruments used in the treatment of cancer. It offers SentiMag, a surgical instrument for use in the treatment of breast cancer and melanoma by helping surgeons to identify the sentinel lymph node for excision and subsequent histology to determine whether cancer has spread from a nearby tumor site. The company was founded by Quentin Pankhurst, Simon Hattersley, and Audrius Brazdeikis in April 2007 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
PolyTherics Ltd.
 PolyTherics Ltd. Pharmaceuticals: MajorHealth Technology PolyTherics Ltd. develops biomedical polymers for therapeutic applications. The company was founded by Antony Godwin, Sunil Shaunak and Steve Brocchini in 2001 and is headquartered in Babraham, the United Kingdom. | Health Technology |
| Contronics Ltd. | |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Worldwide Business Development Corp.
 Worldwide Business Development Corp. Financial ConglomeratesFinance Worldwide Business Development Corp. provides professional training and coaching services. The company is headquartered in Toronto, Canada. | Finance |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
